Patents by Inventor Peter Hadley Jones

Peter Hadley Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5869513
    Abstract: This invention relates to 2-?(1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines that are useful in the treatment and prevention of ulcers.
    Type: Grant
    Filed: May 24, 1985
    Date of Patent: February 9, 1999
    Assignee: G. D. Searle & Co.
    Inventors: Gilbert William Adelstein, Peter Hadley Jones, Chung-Hwai Yen
  • Patent number: 5827925
    Abstract: A drug delivery system adapted to release an effective amount of a drug at pH values of about 1 to 7 without releasing a significant amount of the drug at pH values of about 7 and above, the system comprising a polymeric material and a drug covalently bonded to the polymeric material through a pH sensitive covalent bond capable of being cleaved in the pH range of 1 to about 7.
    Type: Grant
    Filed: November 2, 1993
    Date of Patent: October 27, 1998
    Assignee: Monsanto Company
    Inventors: Samuel J. Tremont, Paul Waddell Collins, William Eldredge Perkins, Peter Hadley Jones
  • Patent number: 4112097
    Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
    Type: Grant
    Filed: January 21, 1977
    Date of Patent: September 5, 1978
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
  • Patent number: 4058559
    Abstract: This invention provides 4-aroyl substituted phenoxy acetic acids and tetrazoles of the formula ##STR1## wherein R is a phenyl ring, a substituted phenyl ring, or naphthyl; R.sub.1 is --CH.sub.2 COOH or methyl tetrazole, and X.sub.1 and X.sub.2 are each a halogen or loweralkyl, or when taken together form with the two attached carbons a phenyl ring.These compounds are useful as antihypertensive agents, diuretics and uricosuric agents.
    Type: Grant
    Filed: September 24, 1975
    Date of Patent: November 15, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Dilbagh Singh Bariana, Anthony Kei Lun Fung, Yvonne Connolly Martin, Jaroslav Kyncl, Amrit Lall
  • Patent number: 4031242
    Abstract: This invention covers diacylated derivatives of .gamma.-glutamyl dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C.sub.1 -C.sub.7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.The compounds of this invention are useful to increase the renal blood flow by being administered to warm-blooded animals by clinically accepted routes of administration such as oral, parenteral, rectal and the like.
    Type: Grant
    Filed: September 11, 1975
    Date of Patent: June 21, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Carroll Wayne Ours, Jaroslav Kyncl
  • Patent number: 4026894
    Abstract: Described are antihypertensive agents selected from the class consisting of 2[4(tetrahydro-2-furoyl)-piperazino]-4-amino-6,7-dimethoxyquinazoline and 2-[4(tetrahydropyran-2-carbonyl)-piperazinyl]-4-amino-6,7-dimethoxyquinazo line, and pharmaceutically acceptable acid addition salts thereof. The compounds are highly water soluble and can be administered in time release form as well as parenterally, including intravenously.
    Type: Grant
    Filed: October 14, 1975
    Date of Patent: May 31, 1977
    Assignee: Abbott Laboratories
    Inventors: Martin Winn, Jaroslav Kyncl, Daniel Ambrose Dunnigan, Peter Hadley Jones
  • Patent number: 4017636
    Abstract: Covers the esters of .gamma.-glutamyl amide of dopamine selected from the group consisting of ##STR1## where R is a C.sub.1 -C.sub.18 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of .gamma.-glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.
    Type: Grant
    Filed: September 24, 1975
    Date of Patent: April 12, 1977
    Assignee: Abbott Laboratories
    Inventors: Peter Hadley Jones, Jaroslav Kyncl, Carroll Wayne Ours, Pitambar Somani